IMDX

Insight Molecular Diagnostics
IMDX

Overview Fund Trends Analyst Outlook Journalist POV

50 hedge funds and large institutions have $63.7M invested in Insight Molecular Diagnostics in 2019 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 12 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

0.53% more ownership

Funds ownership: 1.02% → 1.55% (+0.53%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
50
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$9.84M
2
+$5.09M
3
+$3.62M
4
SSA
Schonfeld Strategic Advisors
New York
+$3.43M
5
BC
Broadwood Capital
New York
+$2.11M

Top Sellers

1
-$17K
2
-$2.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$32M
2
$9.84M
3
$5.09M
4
$4.97M
5
$3.43M
6
$961K
7
$903K
8
$770K
9
$744K
10
$699K
11
$670K
12
$538K
13
$497K
14
$266K
15
$220K
16
$181K
17
$167K
18
$159K
19
$126K
20
$118K
21
$117K
22
$114K
23
$114K
24
$99K
25
$99K
1
2